Controversy and debate on dengue vaccine —paper 3: final response to Review of a licensed dengue vaccine: Inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs
In their response to our critique [1] of their article, Hadinegoro et al. question us on three issues [2].
Source: Journal of Clinical Epidemiology - Category: Epidemiology Authors: Antonio L. Dans, Leonila F. Dans, Mary Ann D. Lansang, Maria Asuncion A. Silvestre, Gordon H. Guyatt Tags: Letter to the Editor Source Type: research